This combination tablet contains Dapagliflozin 10mg, Glimepiride 2mg, and Metformin Hydrochloride 1000mg (Extended Release). It is specifically formulated for adults with type 2 diabetes mellitus who require better glycemic control. Dapagliflozin is an SGLT2 inhibitor that helps lower blood sugar by promoting glucose excretion via urine. Glimepiride is a sulfonylurea that stimulates insulin secretion from pancreatic beta cells. Metformin Hydrochloride ER improves insulin sensitivity and reduces hepatic glucose production. The extended-release formulation ensures a sustained effect, helping maintain stable blood sugar levels throughout the day with once-daily dosing. This combination is particularly useful for patients inadequately controlled on monotherapy or dual therapy.
